276 related articles for article (PubMed ID: 26627256)
1. Post-conversion sialylation of prions in lymphoid tissues.
Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
3. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
Makarava N; Chang JC; Baskakov IV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
[TBL] [Abstract][Full Text] [Related]
4. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
5. Sialylation Controls Prion Fate
Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
[TBL] [Abstract][Full Text] [Related]
6. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.
Katorcha E; Srivastava S; Klimova N; Baskakov IV
J Biol Chem; 2016 Aug; 291(33):17009-19. PubMed ID: 27317661
[TBL] [Abstract][Full Text] [Related]
8. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
9. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
10. Role of sialylation of N-linked glycans in prion pathogenesis.
Makarava N; Baskakov IV
Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
[TBL] [Abstract][Full Text] [Related]
11. PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie.
Sørby R; Austbø L; Press CM; Skretting G; Landsverk T; Espenes A
PLoS One; 2009 Sep; 4(9):e6885. PubMed ID: 19727393
[TBL] [Abstract][Full Text] [Related]
12. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Covalent Modifications of Amyloidogenic Proteins Using Two-Dimensional Electrophoresis: Prion Protein and Its Sialylation.
Katorcha E; Baskakov IV
Methods Mol Biol; 2018; 1779():241-255. PubMed ID: 29886537
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
15. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
16. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
17. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and structure of PrP(C) and PrP(Sc).
Riesner D
Br Med Bull; 2003; 66():21-33. PubMed ID: 14522846
[TBL] [Abstract][Full Text] [Related]
19. Subclinical prion disease induced by oral inoculation.
Thackray AM; Klein MA; Bujdoso R
J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]